Smith W M
Am J Cardiol. 1985 Jan 11;55(2):3A-8A. doi: 10.1016/0002-9149(85)90789-1.
Despite the paucity of epidemiologic work on congestive heart failure (CHF), the salient features of the natural course of cardiac failure are understood. The estimated 1983 incidence of CHF in the United States was 214,000 men and 184,000 women. The estimate of prevalence was 2.3 million persons, with a remarkable increase with advancing age and higher rates in men than women at all ages. Overt heart disease plus age are the principal determinants of the incidence of CHF. Nearly 90% of patients with CHF have systemic hypertension or coronary heart disease, or both, as the antecedent underlying condition. Diabetes mellitus increases the risk of CHF at all ages, particularly in women and those treated with insulin. The prognosis after diagnosis of CHF is grim and is related to the degree of myocardial dysfunction. The challenge is to develop more effective drugs not only for the management of overt CHF, but also for the prevention of its progression.
尽管关于充血性心力衰竭(CHF)的流行病学研究较少,但心力衰竭自然病程的显著特征已为人所知。据估计,1983年美国CHF的发病率为男性21.4万例,女性18.4万例。患病率估计为230万人,随着年龄增长显著增加,且各年龄段男性患病率均高于女性。明显的心脏病加上年龄是CHF发病率的主要决定因素。近90%的CHF患者先前存在全身性高血压或冠心病,或两者皆有。糖尿病在各年龄段都会增加CHF的风险,尤其是女性和接受胰岛素治疗的患者。CHF诊断后的预后严峻,且与心肌功能障碍程度有关。挑战在于研发更有效的药物,不仅用于治疗显性CHF,还用于预防其进展。